These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36766444)

  • 1. R4Alz-Revised: A Tool Able to Strongly Discriminate 'Subjective Cognitive Decline' from Healthy Cognition and 'Minor Neurocognitive Disorder'.
    Poptsi E; Moraitou D; Tsardoulias E; Symeonidis AL; Papaliagkas V; Tsolaki M
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the Discrimination of Subjective Cognitive Decline from Cognitively Healthy Adulthood and Mild Cognitive Impairment Possible? A Pilot Study Utilizing the R4Alz Battery.
    Poptsi E; Moraitou D; Tsardoulias E; Symeonidisd AL; Tsolaki M
    J Alzheimers Dis; 2020; 77(2):715-732. PubMed ID: 32741834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    Poptsi E; Tsardoulias E; Moraitou D; Symeonidis AL; Tsolaki M
    J Alzheimers Dis; 2019; 72(3):783-801. PubMed ID: 31640100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Lazarou I; Moraitou D; Papatheodorou M; Vavouras I; Lokantidou C; Agogiatou C; Gialaoutzis M; Nikolopoulos S; Stavropoulos TG; Kompatsiaris I; Tsolaki M
    J Alzheimers Dis; 2021; 84(3):1219-1232. PubMed ID: 34657882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An application study-subjective cognitive decline Questionnaire9 in detecting mild cognitive impairment (MCI).
    Hao L; Jia J; Xing Y; Han Y
    Aging Ment Health; 2022 Oct; 26(10):2014-2021. PubMed ID: 34583593
    [No Abstract]   [Full Text] [Related]  

  • 7. Subjective cognitive decline in patients with mild cognitive impairment and healthy older adults: association with personality traits.
    Studer J; Donati A; Popp J; von Gunten A
    Geriatr Gerontol Int; 2014 Jul; 14(3):589-95. PubMed ID: 23992484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia.
    Poptsi E; Moraitou D; Eleftheriou M; Kounti-Zafeiropoulou F; Papasozomenou C; Agogiatou C; Bakoglidou E; Batsila G; Liapi D; Markou N; Nikolaidou E; Ouzouni F; Soumpourou A; Vasiloglou M; Tsolaki M
    J Geriatr Psychiatry Neurol; 2019 Sep; 32(5):265-274. PubMed ID: 31159629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia.
    Liew TM
    Alzheimers Res Ther; 2020 Sep; 12(1):107. PubMed ID: 32917264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self- and informant-reported cognitive functioning and awareness in subjective cognitive decline, mild cognitive impairment, and very mild Alzheimer disease.
    Ryu SY; Kim A; Kim S; Park KW; Park KH; Youn YC; Lee DW; Lee JY; Lee JH; Jeong JH; Choi SH; Han HJ; Kim S; Na S; Park M; Yim HW; Yang DW
    Int J Geriatr Psychiatry; 2020 Jan; 35(1):91-98. PubMed ID: 31650618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Validity of the Smart Aging Serious Game: An Innovative Tool for Digital Phenotyping of Mild Neurocognitive Disorder.
    Isernia S; Cabinio M; Di Tella S; Pazzi S; Vannetti F; Gerli F; Mosca IE; Lombardi G; Macchi C; Sorbi S; Baglio F
    J Alzheimers Dis; 2021; 83(4):1789-1801. PubMed ID: 34459394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signs and symptoms method in neuropsychology: A standardized observational examination of cognitive functions can be effective in detecting mild cognitive impairment.
    Trimarchi PD; Sanfilippo E; Gallucci A; Inglese S; Tomasini E; Fontanella A; Rebecchi I; Fracchia S; Parisi PMR; Tartarone F; Giunco F; Abbate C
    Neuropsychology; 2023 Oct; 37(7):846-857. PubMed ID: 36442006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study.
    Rami L; Mollica MA; García-Sanchez C; Saldaña J; Sanchez B; Sala I; Valls-Pedret C; Castellví M; Olives J; Molinuevo JL
    J Alzheimers Dis; 2014; 41(2):453-66. PubMed ID: 24625794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
    J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
    Tsatali M; Fotiadou F; Giaglis G; Tsolaki M
    Aging Clin Exp Res; 2019 Sep; 31(9):1305-1312. PubMed ID: 30471005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a Relation Between Hippocampal Volume, White Matter Hyperintensities, and Cognition in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Caillaud M; Hudon C; Boller B; Brambati S; Duchesne S; Lorrain D; Gagnon JF; Maltezos S; Mellah S; Phillips N; ; Belleville S
    J Gerontol B Psychol Sci Soc Sci; 2020 Aug; 75(7):1382-1392. PubMed ID: 31758692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment.
    Dwolatzky T; Whitehead V; Doniger GM; Simon ES; Schweiger A; Jaffe D; Chertkow H
    J Mol Neurosci; 2004; 24(1):33-44. PubMed ID: 15314247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PER2 C111G polymorphism, cognitive reserve and cognition in subjective cognitive decline and mild cognitive impairment: a 10-year follow-up study.
    Bessi V; Giacomucci G; Mazzeo S; Bagnoli S; Padiglioni S; Balestrini J; Tomaiuolo G; Piaceri I; Carraro M; Bracco L; Sorbi S; Nacmias B
    Eur J Neurol; 2021 Jan; 28(1):56-65. PubMed ID: 32896064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetry of Hippocampus and Amygdala Defect in Subjective Cognitive Decline Among the Community Dwelling Chinese.
    Yue L; Wang T; Wang J; Li G; Wang J; Li X; Li W; Hu M; Xiao S
    Front Psychiatry; 2018; 9():226. PubMed ID: 29942265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.